Filing Details
- Accession Number:
- 0000899243-21-040972
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-10-21 16:52:16
- Reporting Period:
- 2021-10-19
- Accepted Time:
- 2021-10-21 16:52:16
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1809519 | Goodrx Holdings Inc. | GDRX | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1632311 | Bansi Nagji | C/O Goodrx Holdings, Inc. 2701 Olympic Boulevard Santa Monica CA 90404 | President, Healthcare | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Class A Common Stock | Acquisiton | 2021-10-19 | 100 | $6.84 | 100 | No | 4 | M | Direct | |
Class A Common Stock | Disposition | 2021-10-19 | 100 | $45.02 | 0 | No | 4 | S | Direct | |
Class A Common Stock | Acquisiton | 2021-10-20 | 16,300 | $6.84 | 16,300 | No | 4 | M | Direct | |
Class A Common Stock | Disposition | 2021-10-20 | 16,300 | $45.00 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Class A Common Stock | Stock Option (Right to Buy) | Disposition | 2021-10-19 | 100 | $0.00 | 100 | $6.84 |
Class A Common Stock | Stock Option (Right to Buy) | Disposition | 2021-10-19 | 16,300 | $0.00 | 16,300 | $6.84 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
305,884 | 2030-06-15 | No | 4 | M | Direct | |
289,584 | 2030-06-15 | No | 4 | M | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
- The option vested and became exercisable as to 25,000 shares on the closing date of the Issuer's initial public offering of securities, and vested or will vest as to 1/48th of the original 400,000 shares monthly thereafter until fully vested on June 10, 2024.